OPKO Health, Inc. – NASDAQ:OPK

OPKO Health stock price today

$1.35
-0.12
-8.78%
Financial Health
0
1
2
3
4
5
6
7
8
9

OPKO Health stock price monthly change

+7.25%
month

OPKO Health stock price quarterly change

+7.25%
quarter

OPKO Health stock price yearly change

-6.33%
year

OPKO Health key metrics

Market Cap
1.03B
Enterprise value
1.24B
P/E
-3.15
EV/Sales
1.23
EV/EBITDA
-4.57
Price/Sales
1.08
Price/Book
0.69
PEG ratio
N/A
EPS
-0.34
Revenue
799.60M
EBITDA
-120.67M
Income
-252.48M
Revenue Q/Q
-26.89%
Revenue Y/Y
-12.38%
Profit margin
-32.7%
Oper. margin
-24.51%
Gross margin
28.7%
EBIT margin
-24.51%
EBITDA margin
-15.09%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

OPKO Health stock price history

OPKO Health stock forecast

OPKO Health financial statements

OPKO Health, Inc. (NASDAQ:OPK): Profit margin
Jun 2023 265.41M -19.64M -7.4%
Sep 2023 178.6M -84.5M -47.31%
Dec 2023 181.9M -66.50M -36.56%
Mar 2024 173.68M -81.83M -47.12%
OPKO Health, Inc. (NASDAQ:OPK): Analyst Estimates
Sep 2025 205.39M -44.16M -21.5%
Oct 2025 190.47M -44.18M -23.19%
Dec 2025 198.67M -40.64M -20.46%
Mar 2026 940.73M 2.02M 0.22%
  • Analysts Price target

  • Financials & Ratios estimates

OPKO Health, Inc. (NASDAQ:OPK): Debt to assets
Jun 2023 2158899000 623.55M 28.88%
Sep 2023 2056700000 612.1M 29.76%
Dec 2023 2011698000 622.47M 30.94%
Mar 2024 1974016000 721.20M 36.54%
OPKO Health, Inc. (NASDAQ:OPK): Cash Flow
Jun 2023 -365K -5.49M 3.46M
Sep 2023 33.10M -3.57M 2.10M
Dec 2023 -38.29M -1.41M -3.75M
Mar 2024 -35.56M -4.39M 20.61M

OPKO Health alternative data

OPKO Health, Inc. (NASDAQ:OPK): Employee count
Aug 2023 4,196
Sep 2023 4,196
Oct 2023 4,196
Nov 2023 4,196
Dec 2023 4,196
Jan 2024 4,196
Feb 2024 4,196
Mar 2024 3,930
Apr 2024 3,930
May 2024 3,930
Jun 2024 3,930
Jul 2024 3,930

OPKO Health other data

18.98% -10.40%
of OPK is owned by hedge funds
125.29M -65.05M
shares is hold by hedge funds

OPKO Health, Inc. (NASDAQ:OPK): Insider trades (number of shares)
Period Buy Sel
Jan 2024 5068025 0
Feb 2024 3000000 0
Mar 2024 2100000 0
May 2024 263997 0
Sep 2024 0 0
Nov 2024 679255 0
Dec 2024 625000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
FROST PHILLIP MD ET AL director, 10 perc.. Common Stock 125,000 $1.6 $199,375
Purchase
FROST PHILLIP MD ET AL director, 10 perc.. Common Stock 125,000 $1.6 $199,375
Purchase
FROST PHILLIP MD ET AL director, 10 perc.. Common Stock 500,000 $1.56 $781,000
Purchase
FROST PHILLIP MD ET AL director, 10 perc.. Common Stock 500,000 $1.56 $781,000
Purchase
FROST PHILLIP MD ET AL director, 10 perc.. Common Stock 199,072 $1.53 $305,376
Purchase
FROST PHILLIP MD ET AL director, 10 perc.. Common Stock 199,072 $1.53 $305,376
Purchase
FROST PHILLIP MD ET AL director, 10 perc.. Common Stock 100,000 $1.59 $159,000
Purchase
FROST PHILLIP MD ET AL director, 10 perc.. Common Stock 100,000 $1.59 $159,000
Purchase
FROST PHILLIP MD ET AL director, 10 perc.. Common Stock 100,000 $1.62 $162,000
Purchase
FROST PHILLIP MD ET AL director, 10 perc.. Common Stock 100,000 $1.62 $162,000
Monday, 18 November 2024
prnewswire.com
Friday, 8 November 2024
zacks.com
Thursday, 7 November 2024
zacks.com
seekingalpha.com
zacks.com
Friday, 11 October 2024
zacks.com
Monday, 7 October 2024
prnewswire.com
globenewswire.com
Wednesday, 2 October 2024
zacks.com
Thursday, 26 September 2024
zacks.com
Monday, 16 September 2024
prnewswire.com
Thursday, 8 August 2024
zacks.com
Wednesday, 7 August 2024
zacks.com
globenewswire.com
Wednesday, 17 July 2024
globenewswire.com
Thursday, 6 June 2024
zacks.com
Friday, 31 May 2024
globenewswire.com
investorplace.com
Thursday, 9 May 2024
Zacks Investment Research
Tuesday, 7 May 2024
Zacks Investment Research
Zacks Investment Research
Friday, 3 May 2024
GlobeNewsWire
Monday, 1 April 2024
Zacks Investment Research
Monday, 25 March 2024
Zacks Investment Research
Wednesday, 28 February 2024
Zacks Investment Research
Tuesday, 27 February 2024
Zacks Investment Research
Seeking Alpha
Zacks Investment Research
Thursday, 22 February 2024
GlobeNewsWire
Monday, 22 January 2024
InvestorPlace
  • What's the price of OPKO Health stock today?

    One share of OPKO Health stock can currently be purchased for approximately $1.35.

  • When is OPKO Health's next earnings date?

    Unfortunately, OPKO Health's (OPK) next earnings date is currently unknown.

  • Does OPKO Health pay dividends?

    No, OPKO Health does not pay dividends.

  • How much money does OPKO Health make?

    OPKO Health has a market capitalization of 1.03B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 14.01% to 863.5M US dollars.

  • What is OPKO Health's stock symbol?

    OPKO Health, Inc. is traded on the NASDAQ under the ticker symbol "OPK".

  • What is OPKO Health's primary industry?

    Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.

  • How do i buy shares of OPKO Health?

    Shares of OPKO Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are OPKO Health's key executives?

    OPKO Health's management team includes the following people:

    • Dr. Jon R. Cohen Senior Vice President & Director(age: 70, pay: $1,740,000)
    • Mr. Adam E. Logal Senior Vice President & Chief Financial Officer(age: 47, pay: $1,110,000)
    • Dr. Phillip Frost Ph.D. Chairman & Chief Executive Officer(age: 89, pay: $971,200)
    • Dr. Jane H. Hsiao Ph.D., MBA Vice Chairman & Chief Technical Officer(age: 78, pay: $911,200)
    • Mr. Steven D. Rubin Executive Vice President of Admin. & Director(age: 65, pay: $821,200)
  • How many employees does OPKO Health have?

    As Jul 2024, OPKO Health employs 3,930 workers.

  • When OPKO Health went public?

    OPKO Health, Inc. is publicly traded company for more then 29 years since IPO on 2 Nov 1995.

  • What is OPKO Health's official website?

    The official website for OPKO Health is opko.com.

  • Where are OPKO Health's headquarters?

    OPKO Health is headquartered at 4400 Biscayne Boulevard, Miami, FL.

  • How can i contact OPKO Health?

    OPKO Health's mailing address is 4400 Biscayne Boulevard, Miami, FL and company can be reached via phone at +30 55754100.

OPKO Health company profile:

OPKO Health, Inc.

opko.com
Exchange:

NASDAQ

Full time employees:

3,930

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. The company also offers specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, it operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.

4400 Biscayne Boulevard
Miami, FL 33137

CIK: 0000944809
ISIN: US68375N1037
CUSIP: 68375N103